Evotec (www.evotec.com) is a drug discovery alliance and development partnership company with extensive experience in and capabilities for driving innovative drug candidates from initial concept all the way through to the clinic. Our expertise spans many therapeutic areas, all modalities, including small molecules, biologics as well as cell and gene therapy, and collaborations across different industries. We operate globally with over 3,400 employees, most of whom are scientists with vast multidisciplinary expertise.

Evotec, along with its subsidiaries, provides a comprehensive service offering with both high-quality standalone and fully integrated support throughout the drug discovery and development process. We have the experience and expertise to carefully guide you through the necessary steps and regulatory requirements in order to successfully bring a drug candidate to the clinic and beyond.

Additionally, Evotec offers drug discovery and development alliances and partnering opportunities for its proprietary research projects. Our current network of partnerships extends across a range of companies and institutions including leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. Our focus is to rapidly progress innovative products.